Scleroderma Diagnostics and Therapeutics Market Scleroderma Diagnostics and Therapeutics Market - | Página 4
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2498
The global scleroderma therapeutics and diagnostics market has been segmented as follows:
Global Scleroderma Therapeutics Market, by Drug Class
Corticosteroids
Immunosuppressive Agents
Endothelin Receptor Agonists
Calcium Channel Blockers
PDE-5 Inhibitors
Chelating Agents
Prostacyclin Analogues
Others (H2 Blockers, Proton Pump Inhibitors, ACE Inhibitors etc.)
Global Scleroderma Therapeutics Market, by Indication
Localized
Systemic
Global Scleroderma Diagnostics Market, by Test Type
Skin Biopsy
Imaging Techniques
Blood Tests
Electrocardiogram and Echocardiogram
Pulmonary Function Tests
Global Scleroderma Diagnostics and Therapeutics Market, by Geography
North America
o U.S.
o Canada
Asia Pacific
o India
o China
o Japan
o Rest of APAC
Europe
o France
o Germany
o U.K.
o Rest of Europe
Latin America
o Brazil
o Mexico
o Rest of Latin America
Middle East & Africa
o UAE
o South Africa
o Rest of Middle East & Africa